Posts by Rachel C. Sisodia, MD
Review: Lesions of the Ovary and Fallopian Tube
Rachel C. Sisodia, MD, and Marcela G. del Carmen, MD, MPH, emphasize that all patients with a high-risk lesion of the ovary or fallopian tube should be referred to a gynecologic oncologist, as multiple studies have shown comprehensive surgical staging and tumor debulking is associated with improved overall survival.
Prophylactic Surgery for Patients at High Risk of Ovarian Cancer Decreases Sexual Function, Quality of Life
Researchers in the Center for Gynecologic Oncology found that among patients at high genetic risk of ovarian cancer who undergo prophylactic surgery, health-related worry and tension decline post-operatively, but sexual dysfunction and short-term quality of life are poorer.
Improving Care for Gynecologic Cancers Through Patient Reported Outcomes
In this video, Rachel Sisodia, MD, discusses how incorporating patient voice into their care via patient-reported outcomes can improve their care journey and health outcomes.
Society of Gynecologic Oncology Calls on Clinicians to Measure Patient-Reported Outcomes Routinely
Massachusetts General Hospital oncologists participated in a professional society panel that recommends using a general quality-of-life questionnaire and disease-specific patient-reported outcome measures to assess women with gynecologic malignancies.
How Patient-Reported Outcome Measures Help Improve Patient Care
In 2014, Mass General embraced a plan to design and implement a large-scale patient-reported outcome measures (PROMs) project across 90 specialties. The Department of Obstetrics and Gynecology has been a leader in PROMs with robust collection in Gynecologic Oncology, Obstetrics, and Pelvic Floor Disorders.
As a Gynecologic Oncologist my expertise is in performing complex surgeries and administering oncologic treatments for cancers of the ovary, uterus, cervix, vulva, vagina and other conditions. As a physician, I feel it is our duty to be incredibly kind to our patients and to partner with them to fight this challenge together, as a team. My deepest commitment is to perform each woman's surgery expertly and in pursuit of the best possible outcome that we can obtain for her, while minimizing the risk of complications. I leverage this commitment to quality of care in my work as the Chief Quality Officer for Mass General Brigham. In this role I am responsible for the quality and safety of all health care provided throughout our system, spanning thirteen hospitals, thousands of physicians, and millions of patient lives. While my clinical interest is primarily in providing high quality, safe, excellent surgical and clinical care, as a mother myself, I also have a particular passion in utilizing the newest research and techniques to thoughtfully care for young women with gynecologic cancers who still desire to have children or build their families. I am deeply honored to practice here at Mass General, where experts from all over the country work together and allow us to ensure each patient receives world class care.
I obtained my medical degree from Emory University and completed residency in Obstetrics & Gynecology at the combined Brigham & Women's/Massachusetts General Hospital program at Harvard. Following residency, I completed my fellowship training in Gynecologic Oncology at the Massachusetts General Hospital. Currently, I am Associate Professor at Harvard Medical School, where my research is in the science of balancing what is most important to the patient (quality of life, body function and image, reproductive outcomes and goals for their life) with what is medically required to cure their cancer or lengthen their life, a field of study known as Patient Reported Outcomes. I lecture nationally and internationally on this topic, have published over 80 peer reviewed articles and book chapters, sit on numerous national advisory boards and serve as a Co-Chair of the Quality Committee of our national governing body in Gynecologic Oncology.